Weekly Recap | Novavax +6.94%, earnings beat expectationsWeekly Review·Nov 7, 2026 at 10:00 AMNVAX+10.22%
Weekly Recap | NVAX.US this week, consensus target above spotWeekly Review·Oct 24, 2026 at 06:46 AMNVAX+10.22%
Weekly Recap | Novavax -11.69%, biotech rally takes a breatherWeekly Review·Oct 17, 2026 at 07:48 AMNVAX+10.22%
Weekly Recap | Novavax +21.89%, flows turn net sellerWeekly Review·Oct 10, 2026 at 07:20 AMNVAX+10.22%
Weekly Recap | Novavax -1.6%, consensus target a third aboveWeekly Review·Oct 3, 2026 at 07:22 AMNVAX+10.22%
Weekly Recap | Novavax +5.14%, consensus target above spotWeekly Review·Sep 26, 2026 at 06:55 AMNVAX+10.22%
Weekly Recap | Novavax +7.32%, outperforming the S&P 500Weekly Review·Sep 19, 2026 at 06:28 AMNVAX+10.22%
Weekly Recap | Novavax +10.37%, consensus target above spotWeekly Review·Sep 5, 2026 at 07:33 AMNVAX+10.22%
Weekly Recap | Novavax +3.58%, consensus target above spotWeekly Review·Aug 29, 2026 at 06:08 AMNVAX+10.22%
